Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Azepines | 34 | 2021 | 329 | 2.600 |
Why?
|
Triazoles | 33 | 2021 | 905 | 2.030 |
Why?
|
Nuclear Proteins | 39 | 2023 | 5808 | 1.900 |
Why?
|
Transcription Factors | 47 | 2023 | 12174 | 1.270 |
Why?
|
Proto-Oncogene Proteins c-myc | 17 | 2023 | 998 | 1.040 |
Why?
|
Histone Deacetylase Inhibitors | 11 | 2019 | 776 | 0.890 |
Why?
|
Neuroblastoma | 6 | 2022 | 1265 | 0.830 |
Why?
|
Proteins | 13 | 2022 | 6008 | 0.830 |
Why?
|
Adipogenesis | 2 | 2019 | 370 | 0.650 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2022 | 792 | 0.600 |
Why?
|
Drug Resistance, Neoplasm | 16 | 2021 | 5342 | 0.590 |
Why?
|
Cell Cycle Proteins | 27 | 2023 | 3463 | 0.560 |
Why?
|
Gene Expression Regulation, Neoplastic | 25 | 2021 | 8635 | 0.550 |
Why?
|
Chromatin | 20 | 2023 | 2969 | 0.540 |
Why?
|
Cell Line, Tumor | 49 | 2023 | 17149 | 0.540 |
Why?
|
Lysine | 1 | 2021 | 989 | 0.530 |
Why?
|
Epigenesis, Genetic | 13 | 2023 | 3826 | 0.520 |
Why?
|
Proteasome Endopeptidase Complex | 4 | 2020 | 1322 | 0.510 |
Why?
|
Multiple Myeloma | 8 | 2023 | 5192 | 0.500 |
Why?
|
Hydroxamic Acids | 5 | 2019 | 482 | 0.500 |
Why?
|
Enhancer Elements, Genetic | 10 | 2021 | 1368 | 0.490 |
Why?
|
Histones | 5 | 2022 | 2595 | 0.480 |
Why?
|
Antineoplastic Agents | 20 | 2020 | 13708 | 0.460 |
Why?
|
alpha-Synuclein | 1 | 2020 | 765 | 0.440 |
Why?
|
Methyltransferases | 4 | 2022 | 375 | 0.440 |
Why?
|
Xenograft Model Antitumor Assays | 18 | 2021 | 3619 | 0.410 |
Why?
|
E1A-Associated p300 Protein | 2 | 2022 | 125 | 0.370 |
Why?
|
Methylation | 4 | 2022 | 1077 | 0.370 |
Why?
|
Mice | 61 | 2022 | 82045 | 0.360 |
Why?
|
Histone Deacetylases | 5 | 2019 | 717 | 0.350 |
Why?
|
Leukemia | 5 | 2020 | 1527 | 0.350 |
Why?
|
RNA Polymerase II | 6 | 2021 | 547 | 0.350 |
Why?
|
Histone Deacetylase 1 | 3 | 2016 | 133 | 0.340 |
Why?
|
Cerebellar Neoplasms | 3 | 2019 | 590 | 0.340 |
Why?
|
Leukemia, Myeloid, Acute | 8 | 2022 | 3623 | 0.330 |
Why?
|
Medulloblastoma | 3 | 2019 | 682 | 0.330 |
Why?
|
Animals | 75 | 2022 | 169418 | 0.320 |
Why?
|
Cell Proliferation | 27 | 2021 | 10494 | 0.320 |
Why?
|
Bronchiolitis Obliterans | 2 | 2022 | 220 | 0.310 |
Why?
|
Enzyme Inhibitors | 6 | 2022 | 3734 | 0.310 |
Why?
|
Neoplasms | 8 | 2022 | 22386 | 0.300 |
Why?
|
Germinal Center | 2 | 2022 | 379 | 0.290 |
Why?
|
Extinction, Psychological | 2 | 2021 | 371 | 0.290 |
Why?
|
Dihydropyridines | 2 | 2021 | 67 | 0.290 |
Why?
|
Lactams | 2 | 2021 | 158 | 0.280 |
Why?
|
Gene Expression Regulation, Leukemic | 4 | 2020 | 656 | 0.280 |
Why?
|
Histone-Lysine N-Methyltransferase | 4 | 2022 | 697 | 0.270 |
Why?
|
Isoxazoles | 2 | 2021 | 233 | 0.270 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2021 | 664 | 0.260 |
Why?
|
Acetylation | 5 | 2022 | 1053 | 0.260 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2021 | 384 | 0.260 |
Why?
|
Gene Amplification | 3 | 2021 | 1091 | 0.260 |
Why?
|
Lymphoma, Mantle-Cell | 2 | 2021 | 238 | 0.250 |
Why?
|
Chromatin Assembly and Disassembly | 4 | 2023 | 633 | 0.250 |
Why?
|
Protein Kinase Inhibitors | 6 | 2021 | 5709 | 0.250 |
Why?
|
Folic Acid | 3 | 2021 | 1336 | 0.250 |
Why?
|
Protein Binding | 16 | 2022 | 9376 | 0.240 |
Why?
|
Mice, SCID | 9 | 2021 | 2633 | 0.240 |
Why?
|
Transcription, Genetic | 11 | 2021 | 7599 | 0.240 |
Why?
|
Hedgehog Proteins | 3 | 2022 | 770 | 0.240 |
Why?
|
Transcriptional Activation | 4 | 2023 | 1751 | 0.230 |
Why?
|
Genes, myc | 5 | 2017 | 391 | 0.230 |
Why?
|
Cyclin-Dependent Kinase 9 | 2 | 2021 | 68 | 0.230 |
Why?
|
High-Throughput Screening Assays | 4 | 2019 | 940 | 0.230 |
Why?
|
Cell Survival | 9 | 2021 | 5801 | 0.230 |
Why?
|
Structure-Activity Relationship | 9 | 2022 | 3073 | 0.230 |
Why?
|
Histone Deacetylase 2 | 2 | 2015 | 72 | 0.230 |
Why?
|
Protein Interaction Mapping | 2 | 2019 | 616 | 0.220 |
Why?
|
Memory, Long-Term | 2 | 2021 | 61 | 0.210 |
Why?
|
Pyrimidines | 5 | 2018 | 3050 | 0.210 |
Why?
|
Cyclin-Dependent Kinase 4 | 4 | 2020 | 564 | 0.210 |
Why?
|
Chromosomal Proteins, Non-Histone | 3 | 2023 | 733 | 0.210 |
Why?
|
Mice, Inbred NOD | 7 | 2021 | 1839 | 0.210 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2021 | 2964 | 0.200 |
Why?
|
Frizzled Receptors | 1 | 2022 | 91 | 0.200 |
Why?
|
Signal Transduction | 21 | 2023 | 23638 | 0.200 |
Why?
|
Cyclin-Dependent Kinase 6 | 3 | 2020 | 352 | 0.200 |
Why?
|
HEK293 Cells | 10 | 2020 | 4294 | 0.200 |
Why?
|
Liposarcoma, Myxoid | 1 | 2022 | 60 | 0.200 |
Why?
|
Prostatic Neoplasms | 3 | 2020 | 11206 | 0.190 |
Why?
|
Epigenomics | 2 | 2020 | 956 | 0.190 |
Why?
|
Fear | 2 | 2021 | 1494 | 0.190 |
Why?
|
Glycine Hydroxymethyltransferase | 1 | 2021 | 32 | 0.190 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 4 | 2019 | 1766 | 0.190 |
Why?
|
Retinoblastoma-Binding Protein 2 | 1 | 2021 | 35 | 0.190 |
Why?
|
Humans | 91 | 2023 | 768451 | 0.190 |
Why?
|
RNA-Binding Proteins | 3 | 2021 | 1885 | 0.190 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2022 | 168 | 0.180 |
Why?
|
Genes, cdc | 1 | 2021 | 114 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 2 | 2018 | 190 | 0.180 |
Why?
|
Repressor Proteins | 3 | 2022 | 2987 | 0.180 |
Why?
|
Cell Cycle | 5 | 2021 | 2942 | 0.170 |
Why?
|
Receptors, Cell Surface | 3 | 2020 | 2819 | 0.170 |
Why?
|
Interferon Regulatory Factors | 1 | 2021 | 268 | 0.170 |
Why?
|
Pyridines | 6 | 2021 | 2888 | 0.170 |
Why?
|
SOXB1 Transcription Factors | 1 | 2021 | 286 | 0.160 |
Why?
|
Recombinases | 1 | 2019 | 70 | 0.160 |
Why?
|
Endodeoxyribonucleases | 1 | 2020 | 166 | 0.160 |
Why?
|
Molecular Targeted Therapy | 7 | 2020 | 2834 | 0.160 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2020 | 276 | 0.160 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2019 | 2882 | 0.160 |
Why?
|
Adenosine Deaminase | 1 | 2021 | 253 | 0.160 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2020 | 268 | 0.160 |
Why?
|
Apoptosis | 14 | 2021 | 9526 | 0.160 |
Why?
|
Protein Structure, Tertiary | 6 | 2016 | 3790 | 0.160 |
Why?
|
NF-kappa B | 5 | 2018 | 2491 | 0.160 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2021 | 501 | 0.150 |
Why?
|
Tacrolimus Binding Protein 1A | 1 | 2018 | 40 | 0.150 |
Why?
|
Phenylenediamines | 1 | 2018 | 88 | 0.150 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2019 | 225 | 0.150 |
Why?
|
RNA Interference | 6 | 2021 | 2832 | 0.150 |
Why?
|
Conditioning, Classical | 1 | 2021 | 370 | 0.150 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2022 | 1755 | 0.150 |
Why?
|
CDC2 Protein Kinase | 1 | 2018 | 212 | 0.150 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2019 | 263 | 0.150 |
Why?
|
Graft vs Host Disease | 2 | 2022 | 3042 | 0.150 |
Why?
|
Myofibroblasts | 1 | 2019 | 232 | 0.140 |
Why?
|
Small Molecule Libraries | 3 | 2018 | 746 | 0.140 |
Why?
|
Adenoviruses, Human | 1 | 2019 | 257 | 0.140 |
Why?
|
Iron-Binding Proteins | 1 | 2017 | 83 | 0.140 |
Why?
|
Genetic Techniques | 1 | 2020 | 428 | 0.140 |
Why?
|
Adenine | 2 | 2021 | 993 | 0.140 |
Why?
|
Sarcoma, Synovial | 1 | 2018 | 156 | 0.140 |
Why?
|
Terphenyl Compounds | 1 | 2016 | 7 | 0.140 |
Why?
|
Friedreich Ataxia | 1 | 2017 | 82 | 0.140 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2017 | 129 | 0.140 |
Why?
|
Indazoles | 1 | 2018 | 306 | 0.140 |
Why?
|
Models, Molecular | 7 | 2018 | 5443 | 0.140 |
Why?
|
MicroRNAs | 4 | 2016 | 3805 | 0.140 |
Why?
|
Ligands | 7 | 2018 | 3281 | 0.140 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2019 | 333 | 0.140 |
Why?
|
Neoplastic Stem Cells | 4 | 2022 | 1357 | 0.140 |
Why?
|
Transcriptional Elongation Factors | 1 | 2017 | 167 | 0.130 |
Why?
|
Pancreatic Neoplasms | 3 | 2022 | 5442 | 0.130 |
Why?
|
Crystallography, X-Ray | 5 | 2021 | 1987 | 0.130 |
Why?
|
Metalloproteases | 1 | 2016 | 61 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 3 | 2020 | 4534 | 0.130 |
Why?
|
Rhabdomyosarcoma | 1 | 2019 | 358 | 0.130 |
Why?
|
RNA, Small Interfering | 8 | 2019 | 3437 | 0.130 |
Why?
|
Acoustic Stimulation | 1 | 2021 | 1253 | 0.130 |
Why?
|
Oncogene Proteins v-myb | 1 | 2016 | 26 | 0.130 |
Why?
|
Cell Differentiation | 6 | 2021 | 11674 | 0.130 |
Why?
|
Oncogenes | 1 | 2022 | 1235 | 0.130 |
Why?
|
Open Reading Frames | 1 | 2019 | 812 | 0.130 |
Why?
|
Fibrosis | 2 | 2020 | 2076 | 0.130 |
Why?
|
Glutarates | 1 | 2017 | 243 | 0.130 |
Why?
|
STAT5 Transcription Factor | 2 | 2014 | 268 | 0.130 |
Why?
|
Gene Expression Profiling | 8 | 2022 | 9507 | 0.130 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2016 | 182 | 0.130 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2017 | 305 | 0.130 |
Why?
|
Interleukin-15 | 1 | 2016 | 185 | 0.130 |
Why?
|
Drug Synergism | 5 | 2020 | 1765 | 0.130 |
Why?
|
Calcium-Binding Proteins | 1 | 2020 | 1085 | 0.130 |
Why?
|
Gene Expression Regulation | 6 | 2020 | 11930 | 0.120 |
Why?
|
Glioma | 2 | 2022 | 3523 | 0.120 |
Why?
|
Histone Code | 1 | 2016 | 160 | 0.120 |
Why?
|
Thermodynamics | 1 | 2016 | 594 | 0.120 |
Why?
|
Virus Diseases | 1 | 2021 | 723 | 0.120 |
Why?
|
Molecular Chaperones | 1 | 2019 | 764 | 0.120 |
Why?
|
Drug Delivery Systems | 2 | 2017 | 2238 | 0.120 |
Why?
|
Peptide Mapping | 1 | 2015 | 260 | 0.120 |
Why?
|
Computer-Aided Design | 1 | 2016 | 297 | 0.120 |
Why?
|
B-Lymphocytes | 5 | 2022 | 4781 | 0.120 |
Why?
|
Drug Design | 2 | 2016 | 1050 | 0.120 |
Why?
|
Methotrexate | 1 | 2021 | 1722 | 0.120 |
Why?
|
Receptor, Notch1 | 1 | 2017 | 521 | 0.120 |
Why?
|
Piperidines | 2 | 2021 | 1664 | 0.120 |
Why?
|
Gyrus Cinguli | 1 | 2021 | 1136 | 0.120 |
Why?
|
Oncogene Proteins | 2 | 2022 | 718 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2021 | 2847 | 0.110 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 843 | 0.110 |
Why?
|
Imidazoles | 3 | 2014 | 1174 | 0.110 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2016 | 212 | 0.110 |
Why?
|
Sirtuin 1 | 1 | 2015 | 247 | 0.110 |
Why?
|
Patents as Topic | 1 | 2015 | 113 | 0.110 |
Why?
|
Aorta, Abdominal | 1 | 2016 | 627 | 0.110 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 621 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 2 | 2021 | 2819 | 0.110 |
Why?
|
DNA Helicases | 3 | 2023 | 853 | 0.110 |
Why?
|
Hyperglycemia | 1 | 2022 | 1389 | 0.110 |
Why?
|
Meningioma | 1 | 2022 | 1222 | 0.110 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2016 | 264 | 0.110 |
Why?
|
Contraceptive Agents, Male | 1 | 2012 | 8 | 0.110 |
Why?
|
Meningeal Neoplasms | 1 | 2022 | 1251 | 0.110 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 230 | 0.110 |
Why?
|
Lung Neoplasms | 4 | 2020 | 13589 | 0.100 |
Why?
|
Receptors, Interleukin-7 | 1 | 2012 | 41 | 0.100 |
Why?
|
Neoplasm Transplantation | 4 | 2019 | 2017 | 0.100 |
Why?
|
Neurogenesis | 1 | 2019 | 866 | 0.100 |
Why?
|
Mammals | 3 | 2022 | 1136 | 0.100 |
Why?
|
Iodine Radioisotopes | 1 | 2016 | 1035 | 0.100 |
Why?
|
Up-Regulation | 2 | 2020 | 4138 | 0.100 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2015 | 308 | 0.100 |
Why?
|
Autophagy | 1 | 2020 | 1349 | 0.100 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2014 | 1152 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 1669 | 0.100 |
Why?
|
Tumor Cells, Cultured | 4 | 2021 | 6135 | 0.100 |
Why?
|
Receptors, Cytokine | 1 | 2012 | 257 | 0.100 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1755 | 0.100 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2016 | 687 | 0.100 |
Why?
|
Myeloproliferative Disorders | 1 | 2017 | 614 | 0.090 |
Why?
|
Graft Survival | 2 | 2019 | 3890 | 0.090 |
Why?
|
Retroviridae | 1 | 2014 | 850 | 0.090 |
Why?
|
Memory | 1 | 2021 | 2210 | 0.090 |
Why?
|
Azirines | 1 | 2010 | 30 | 0.090 |
Why?
|
Mice, Inbred C57BL | 9 | 2020 | 22365 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1890 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 1676 | 0.090 |
Why?
|
Binding Sites | 5 | 2021 | 6030 | 0.090 |
Why?
|
Promoter Regions, Genetic | 6 | 2021 | 5803 | 0.090 |
Why?
|
Trans-Activators | 2 | 2017 | 2858 | 0.090 |
Why?
|
Translocation, Genetic | 1 | 2016 | 1395 | 0.090 |
Why?
|
Gene Knockdown Techniques | 4 | 2016 | 1608 | 0.090 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2022 | 1614 | 0.080 |
Why?
|
Nerve Tissue Proteins | 2 | 2020 | 4417 | 0.080 |
Why?
|
Mice, Knockout | 6 | 2021 | 14480 | 0.080 |
Why?
|
Membrane Proteins | 3 | 2016 | 7895 | 0.080 |
Why?
|
DNA Methylation | 2 | 2021 | 4421 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2016 | 945 | 0.080 |
Why?
|
Carrier Proteins | 2 | 2023 | 4948 | 0.080 |
Why?
|
Soft Tissue Neoplasms | 1 | 2018 | 1166 | 0.080 |
Why?
|
Phosphoproteins | 1 | 2018 | 2450 | 0.080 |
Why?
|
Sulfonamides | 1 | 2018 | 1988 | 0.080 |
Why?
|
Immunoblotting | 3 | 2017 | 1650 | 0.080 |
Why?
|
Pyrazines | 1 | 2014 | 1206 | 0.080 |
Why?
|
Pyrazoles | 2 | 2018 | 2024 | 0.080 |
Why?
|
Inflammation | 3 | 2017 | 10865 | 0.080 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2020 | 5426 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2014 | 2465 | 0.080 |
Why?
|
Adipocytes | 1 | 2015 | 1199 | 0.080 |
Why?
|
Hippocampus | 1 | 2021 | 3783 | 0.070 |
Why?
|
Mutation | 8 | 2022 | 30243 | 0.070 |
Why?
|
PTEN Phosphohydrolase | 1 | 2014 | 1119 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 2 | 2018 | 3408 | 0.070 |
Why?
|
Mice, Transgenic | 5 | 2019 | 9558 | 0.070 |
Why?
|
Sequence Analysis, RNA | 3 | 2022 | 2039 | 0.070 |
Why?
|
Mass Spectrometry | 1 | 2015 | 2204 | 0.070 |
Why?
|
Molecular Imaging | 1 | 2014 | 825 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4419 | 0.070 |
Why?
|
NIH 3T3 Cells | 2 | 2020 | 669 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2018 | 2910 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4642 | 0.070 |
Why?
|
Disease Models, Animal | 8 | 2019 | 18388 | 0.070 |
Why?
|
HCT116 Cells | 2 | 2019 | 406 | 0.070 |
Why?
|
Bacterial Proteins | 1 | 2020 | 3861 | 0.070 |
Why?
|
Anemia | 1 | 2016 | 1521 | 0.070 |
Why?
|
Sarcoma | 1 | 2018 | 1806 | 0.070 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2016 | 1252 | 0.070 |
Why?
|
Inhibitory Concentration 50 | 2 | 2019 | 467 | 0.070 |
Why?
|
Adenosine | 3 | 2017 | 816 | 0.060 |
Why?
|
Mice, Nude | 3 | 2018 | 3635 | 0.060 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2021 | 507 | 0.060 |
Why?
|
Anilides | 2 | 2019 | 415 | 0.060 |
Why?
|
Molecular Dynamics Simulation | 2 | 2019 | 434 | 0.060 |
Why?
|
Genome, Human | 4 | 2021 | 4453 | 0.060 |
Why?
|
beta Catenin | 2 | 2022 | 1048 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2016 | 2544 | 0.060 |
Why?
|
Ubiquitin | 2 | 2019 | 843 | 0.060 |
Why?
|
Benzodiazepines | 3 | 2017 | 1139 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10273 | 0.060 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2013 | 1427 | 0.050 |
Why?
|
Drug Discovery | 1 | 2011 | 1062 | 0.050 |
Why?
|
Peptide Elongation Factor 1 | 1 | 2023 | 40 | 0.050 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2012 | 1557 | 0.050 |
Why?
|
Male | 16 | 2022 | 364781 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2014 | 4931 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2016 | 2360 | 0.050 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2023 | 104 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11843 | 0.050 |
Why?
|
Cytokines | 1 | 2017 | 7449 | 0.050 |
Why?
|
Ubiquitination | 2 | 2017 | 1010 | 0.050 |
Why?
|
Binding, Competitive | 2 | 2016 | 1144 | 0.050 |
Why?
|
Janus Kinase 2 | 2 | 2017 | 561 | 0.050 |
Why?
|
Protein Conformation | 2 | 2022 | 3973 | 0.050 |
Why?
|
Hematologic Neoplasms | 1 | 2014 | 1905 | 0.050 |
Why?
|
HeLa Cells | 2 | 2018 | 3090 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2018 | 4906 | 0.050 |
Why?
|
RNA-Binding Protein EWS | 1 | 2023 | 211 | 0.050 |
Why?
|
Esters | 1 | 2022 | 212 | 0.050 |
Why?
|
Cells, Cultured | 4 | 2019 | 19041 | 0.050 |
Why?
|
Thalidomide | 2 | 2017 | 885 | 0.050 |
Why?
|
Mice, Inbred BALB C | 2 | 2020 | 6241 | 0.040 |
Why?
|
RNA, Messenger | 4 | 2018 | 12813 | 0.040 |
Why?
|
U937 Cells | 1 | 2020 | 260 | 0.040 |
Why?
|
Extracellular Matrix | 2 | 2019 | 1738 | 0.040 |
Why?
|
Phenylurea Compounds | 2 | 2015 | 532 | 0.040 |
Why?
|
Endogenous Retroviruses | 1 | 2021 | 112 | 0.040 |
Why?
|
Lactones | 1 | 2022 | 316 | 0.040 |
Why?
|
Gene Silencing | 2 | 2017 | 1503 | 0.040 |
Why?
|
Cell Line | 3 | 2021 | 15609 | 0.040 |
Why?
|
DNA | 1 | 2013 | 7213 | 0.040 |
Why?
|
Ribosomes | 1 | 2023 | 500 | 0.040 |
Why?
|
Amides | 1 | 2022 | 452 | 0.040 |
Why?
|
Ploidies | 1 | 2020 | 287 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2021 | 292 | 0.040 |
Why?
|
Gene Expression | 3 | 2017 | 7605 | 0.040 |
Why?
|
Cyclin D2 | 1 | 2019 | 98 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2022 | 322 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2016 | 1409 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2021 | 515 | 0.040 |
Why?
|
GATA2 Transcription Factor | 1 | 2019 | 158 | 0.040 |
Why?
|
Benzodiazepinones | 1 | 2018 | 50 | 0.040 |
Why?
|
Neoplasms, Experimental | 2 | 2014 | 1232 | 0.040 |
Why?
|
Paired Box Transcription Factors | 1 | 2019 | 206 | 0.040 |
Why?
|
Down-Regulation | 2 | 2018 | 2944 | 0.040 |
Why?
|
Female | 17 | 2021 | 396943 | 0.040 |
Why?
|
K562 Cells | 1 | 2020 | 645 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2017 | 13452 | 0.040 |
Why?
|
Gene Rearrangement | 2 | 2015 | 1139 | 0.040 |
Why?
|
Cell Lineage | 2 | 2019 | 2575 | 0.040 |
Why?
|
Piperazines | 2 | 2020 | 2546 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
Introns | 1 | 2021 | 970 | 0.040 |
Why?
|
Virus Activation | 1 | 2020 | 322 | 0.040 |
Why?
|
Folate Receptor 2 | 1 | 2017 | 5 | 0.040 |
Why?
|
S Phase | 1 | 2019 | 425 | 0.040 |
Why?
|
Thapsigargin | 1 | 2017 | 102 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 712 | 0.040 |
Why?
|
Phenanthrolines | 1 | 2017 | 49 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2018 | 185 | 0.040 |
Why?
|
Molecular Probes | 1 | 2019 | 310 | 0.040 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2021 | 647 | 0.040 |
Why?
|
Gene Library | 1 | 2020 | 1064 | 0.040 |
Why?
|
Virus Latency | 1 | 2020 | 360 | 0.040 |
Why?
|
Fluorometry | 1 | 2017 | 99 | 0.040 |
Why?
|
Molecular Structure | 1 | 2021 | 1889 | 0.040 |
Why?
|
Melanoma | 1 | 2016 | 5740 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 4586 | 0.040 |
Why?
|
Interferons | 1 | 2021 | 714 | 0.040 |
Why?
|
Prognosis | 4 | 2021 | 30028 | 0.030 |
Why?
|
Fluorescence Polarization | 1 | 2017 | 140 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2018 | 2884 | 0.030 |
Why?
|
Structural Homology, Protein | 1 | 2016 | 87 | 0.030 |
Why?
|
E2F3 Transcription Factor | 1 | 2016 | 36 | 0.030 |
Why?
|
Thyroid Hormone Receptors beta | 1 | 2016 | 21 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 808 | 0.030 |
Why?
|
Gene Knock-In Techniques | 1 | 2018 | 423 | 0.030 |
Why?
|
Clone Cells | 1 | 2020 | 1672 | 0.030 |
Why?
|
Cullin Proteins | 1 | 2017 | 180 | 0.030 |
Why?
|
Retinoblastoma Protein | 1 | 2020 | 673 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2017 | 288 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6856 | 0.030 |
Why?
|
Dimerization | 1 | 2018 | 888 | 0.030 |
Why?
|
3T3 Cells | 1 | 2018 | 1086 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 682 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2017 | 9182 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2017 | 743 | 0.030 |
Why?
|
Mediator Complex Subunit 1 | 1 | 2016 | 31 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2022 | 873 | 0.030 |
Why?
|
Isoquinolines | 1 | 2017 | 354 | 0.030 |
Why?
|
Protein Stability | 1 | 2018 | 584 | 0.030 |
Why?
|
Caspases | 1 | 2019 | 884 | 0.030 |
Why?
|
Erythrocyte Indices | 1 | 2016 | 144 | 0.030 |
Why?
|
Benzamides | 1 | 2021 | 1381 | 0.030 |
Why?
|
Phosphoserine | 1 | 2016 | 204 | 0.030 |
Why?
|
Casein Kinase II | 1 | 2016 | 122 | 0.030 |
Why?
|
Alleles | 2 | 2018 | 6890 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2015 | 3794 | 0.030 |
Why?
|
Chronic Disease | 2 | 2022 | 9382 | 0.030 |
Why?
|
Child | 2 | 2022 | 80863 | 0.030 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2017 | 393 | 0.030 |
Why?
|
Ribonucleoproteins | 1 | 2017 | 360 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2015 | 103 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2016 | 542 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2017 | 876 | 0.030 |
Why?
|
Hematocrit | 1 | 2016 | 625 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 11857 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2015 | 130 | 0.030 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2016 | 199 | 0.030 |
Why?
|
Organoids | 1 | 2021 | 749 | 0.030 |
Why?
|
Acyltransferases | 1 | 2016 | 305 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2021 | 11138 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2020 | 1749 | 0.030 |
Why?
|
Cinnamates | 1 | 2014 | 59 | 0.030 |
Why?
|
Databases, Protein | 1 | 2016 | 387 | 0.030 |
Why?
|
Blotting, Western | 2 | 2012 | 5042 | 0.030 |
Why?
|
Transgenes | 1 | 2018 | 1015 | 0.030 |
Why?
|
Genetic Engineering | 1 | 2020 | 936 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2019 | 1706 | 0.030 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2016 | 430 | 0.030 |
Why?
|
Cyclin D1 | 1 | 2016 | 454 | 0.030 |
Why?
|
Disease Progression | 3 | 2018 | 13655 | 0.030 |
Why?
|
Transcription Factor RelA | 1 | 2015 | 254 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3665 | 0.030 |
Why?
|
Biphenyl Compounds | 1 | 2019 | 1026 | 0.030 |
Why?
|
Cytogenetic Analysis | 1 | 2015 | 270 | 0.030 |
Why?
|
Protein Kinases | 1 | 2021 | 1608 | 0.030 |
Why?
|
Protein Phosphatase 2 | 1 | 2016 | 231 | 0.030 |
Why?
|
Mutagenesis | 1 | 2018 | 1230 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2022 | 1898 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1339 | 0.030 |
Why?
|
Genes, bcl-2 | 1 | 2014 | 119 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 17564 | 0.030 |
Why?
|
S-Adenosylmethionine | 1 | 2015 | 220 | 0.030 |
Why?
|
Angiotensin II | 1 | 2016 | 849 | 0.030 |
Why?
|
Cytoplasm | 1 | 2018 | 1503 | 0.030 |
Why?
|
Endocytosis | 1 | 2017 | 960 | 0.030 |
Why?
|
Proteomics | 2 | 2018 | 3901 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2019 | 1615 | 0.030 |
Why?
|
Biological Transport | 1 | 2017 | 2089 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2018 | 1869 | 0.030 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2018 | 977 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 1143 | 0.030 |
Why?
|
Tubulin | 1 | 2016 | 695 | 0.030 |
Why?
|
Blood-Testis Barrier | 1 | 2012 | 12 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2018 | 1136 | 0.030 |
Why?
|
Melanocytes | 1 | 2016 | 512 | 0.030 |
Why?
|
Paclitaxel | 1 | 2020 | 1737 | 0.030 |
Why?
|
Pyridazines | 1 | 2014 | 204 | 0.030 |
Why?
|
Temperature | 1 | 2019 | 2237 | 0.030 |
Why?
|
PPAR gamma | 1 | 2015 | 487 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2013 | 383 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 757 | 0.020 |
Why?
|
Alkanesulfonic Acids | 1 | 2014 | 203 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 873 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2019 | 892 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2012 | 369 | 0.020 |
Why?
|
Rats | 2 | 2019 | 23839 | 0.020 |
Why?
|
Sperm Count | 1 | 2012 | 229 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2019 | 2003 | 0.020 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 1013 | 0.020 |
Why?
|
Quinazolines | 1 | 2018 | 1376 | 0.020 |
Why?
|
Antibodies | 1 | 2019 | 2425 | 0.020 |
Why?
|
Sperm Motility | 1 | 2012 | 266 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2014 | 560 | 0.020 |
Why?
|
Surface Plasmon Resonance | 1 | 2012 | 271 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2017 | 1397 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1660 | 0.020 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2014 | 497 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4355 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2015 | 17647 | 0.020 |
Why?
|
Tretinoin | 1 | 2013 | 525 | 0.020 |
Why?
|
Catalysis | 1 | 2012 | 769 | 0.020 |
Why?
|
Base Sequence | 1 | 2021 | 12428 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 598 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2012 | 856 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2010 | 612 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2014 | 833 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10784 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2015 | 2072 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2012 | 709 | 0.020 |
Why?
|
Fluorocarbons | 1 | 2014 | 505 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2015 | 2224 | 0.020 |
Why?
|
Testis | 1 | 2012 | 783 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3637 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 65409 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2015 | 2525 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2018 | 2058 | 0.020 |
Why?
|
Quinolines | 1 | 2014 | 769 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 2015 | 1781 | 0.020 |
Why?
|
Spermatozoa | 1 | 2012 | 631 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2019 | 8201 | 0.020 |
Why?
|
Doxorubicin | 1 | 2015 | 2229 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2019 | 2757 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2012 | 1775 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5495 | 0.020 |
Why?
|
Peptides | 1 | 2019 | 4368 | 0.020 |
Why?
|
Dexamethasone | 1 | 2015 | 1965 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2019 | 3839 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2017 | 3783 | 0.020 |
Why?
|
Genome | 1 | 2015 | 1749 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3351 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2731 | 0.020 |
Why?
|
RNA | 1 | 2016 | 2727 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3939 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3735 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2010 | 2184 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2072 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2015 | 2434 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2014 | 2048 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6091 | 0.020 |
Why?
|
Indoles | 1 | 2014 | 1834 | 0.020 |
Why?
|
Transfection | 1 | 2013 | 5767 | 0.020 |
Why?
|
Phosphorylation | 1 | 2016 | 8332 | 0.010 |
Why?
|
Macrophages | 1 | 2019 | 5797 | 0.010 |
Why?
|
Nanoparticles | 1 | 2016 | 1986 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6537 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2014 | 3417 | 0.010 |
Why?
|
Kinetics | 1 | 2012 | 6348 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14728 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9505 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5909 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2015 | 3335 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 4984 | 0.010 |
Why?
|
HIV-1 | 1 | 2020 | 6966 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2015 | 3697 | 0.010 |
Why?
|
Zebrafish | 1 | 2014 | 3038 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 2017 | 3197 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5904 | 0.010 |
Why?
|
Lung | 1 | 2019 | 10090 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2010 | 6527 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4298 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16712 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5709 | 0.010 |
Why?
|
Neurons | 1 | 2017 | 9504 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 9425 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2013 | 9623 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2010 | 4083 | 0.010 |
Why?
|
Middle Aged | 2 | 2017 | 223418 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2017 | 59680 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2010 | 5891 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36840 | 0.000 |
Why?
|
Risk Factors | 1 | 2012 | 74915 | 0.000 |
Why?
|
Aged | 1 | 2017 | 171520 | 0.000 |
Why?
|
Adult | 1 | 2017 | 223542 | 0.000 |
Why?
|